Pages About Us Board Careers Contact Us Management News & Press People FCOI Policy Home InVitria Case Study Medicines Infectious Disease VEN BETA Inflammatory Disease VEN120 Newsletter Signup Privacy Policy Site map Technology BioShare Evidence ExpressTec Partnerships Ventria Difference Posts by category Category: In Context CuraVive, the Next Generation Plant-Based Food Ingredients Secretory IgA: potential new weapon against respiratory transmission of SARS-CoV-2? Could IgA from Human Breast Milk Offer Insights into Potential Treatments for COVID-19? Human Milk Proteins: Their Power to Improve the Health Status of Children in Developing Countries Design and Objectives of the ELCIE Clinical Trial Breastmilk and the developing infant brain Studying a potential new insulin analog for diabetes therapy Clinical study: can a protein derived from breastmilk palliate symptoms of inflammation in the elderly? Ventria Bioscience partners with BMGF to address pediatric diarrhea in the developing world Causes of diarrhea in children: The Global Enteric Multicenter Study (GEMS) Protecting American scientific innovation for the greater good Alleviating symptoms of pediatric diarrhea in developing countries Mechanism of Action of rhLactoferrin in Inflammatory Bowel Disease (IBD) Welcome to In Context Category: News - Press Ventria Bioscience wins exclusion order against infringing and mislabled products from Wuhan Healthgen Ventria Bioscience has doubled biomanufacturing capacity for cell culture products Ventria Bioscience Inc. Scores Key Victory in Fight Against Infringing Chinese Recombinant Albumin Ventria Bioscience’s ExpressTec Delivers the Power to Improve the Health Status of Children in Developing Countries Biotech Manufacturing Trends from the Bioprocess International 2018 Conference Digestive Disease Week The Essential Protein Engineering Summit (PEGS) Ventria Bioscience CEO interviewed on CNBC Ventria Bioscience aids global fight against intestinal infections that threaten up to 400 million children a year Ventria Bioscience will double biomanufacturing capacity for therapeutic proteins, reagents and cell culture products Ventria Bioscience announces peer-reviewed publication on novel mechanism of action in inflammatory bowel disease Ventria Wins Economic Development Award Partners Bill & Melinda Gates Foundation Children’s Hospital Colorado and University of Colorado School of Medicine Johns Hopkins School of Medicine UC Davis University of Minnesota